Treating a psychotic syndrome in 2007

Thérapie
Jean-Pierre Olié

Abstract

It is well established that we have to consider 3 patterns of psychotic symptoms: positive (hallucinations, delusion...), negative (affective flatness, autism...) symptoms and disorganization (ambivalence, incoherence...). In the past, ECT (electroconvulsivotherapy) was the first effective treatment in psychiatry. Conventionnal neuroleptics have been determinant in the significant evolution of care to psychotic patients. ECT use is now better defined in terms of practise and indications. Assessment of new antipsychotic medications is mainly focused on efficacy on positive symptoms. Atypical antipsychotics brought improvement in treating psychotic syndromes: they are better tolerated and more effective on the whole spectrum of psychotic syndromes including emotional symptoms than conventional neuroleptics. Atypical antipsychotics have raised questions about metabolic and cardiac risks. Compliance remains a cause of failure of many antipsychotic treatments. Treating a psychotic syndrome requires complementary strategies to medications: conditions of assistance and rehabilitation, choice of psychotherapy. Research program are currently orientated towards: - identification of prepsychotic symptoms and endophenotypes which can be tr...Continue Reading

References

Jan 7, 2003·Archives of General Psychiatry·Herbert Y MeltzerUNKNOWN International Suicide Prevention Trial Study Group
Jun 11, 2003·Archives of General Psychiatry·John M DavisIra D Glick
Nov 25, 2003·The Journal of Clinical Psychiatry·Robert E McCueLeonel Urcuyo
Dec 4, 2003·JAMA : the Journal of the American Medical Association·Robert RosenheckUNKNOWN Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine
Feb 3, 2004·The American Journal of Psychiatry·Erin A HazlettWilliam Byne
Mar 3, 2004·Archives of General Psychiatry·Odin van der SteltAysenil Belger
May 4, 2004·The Journal of Clinical Psychiatry·Jean-Pierre LindenmayerMiranda Chakos
Jun 9, 2004·Archives of General Psychiatry·Cynthia Shannon WeickertJoel E Kleinman
Aug 3, 2004·The American Journal of Psychiatry·Marc BourgeoisUNKNOWN InterSePT Study Group
Sep 1, 2004·The American Journal of Psychiatry·Shameran Slewa-YounanLeanne M Williams
Sep 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·S Hodgins, R Müller-Isberner
Nov 24, 2004·The Journal of Clinical Psychiatry·Stephen M Stahl
May 3, 2005·The American Journal of Psychiatry·Nina SchoolerUNKNOWN Early Psychosis Global Working Group
May 24, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Nick C PatelPeter S Jensen
May 28, 2005·Psychological Medicine·Hannele HeiläJouko Lönnqvist
Sep 21, 2005·The New England Journal of Medicine·Jeffrey A LiebermanUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators

❮ Previous
Next ❯

Citations

Sep 13, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Geneviève DurrieuUNKNOWN French Network of Pharmacovigilance Centres

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.